Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation

Citation
Yang L, Brooks MM, Glynn NW, et al. Am J Cardiol 2020;126:29-36.